Loading...
Loading...
Pharmaceutical Importer Β· #2 buyer for Imatinib Β· $800.0K import value Β· 16 shipments Β· MOROCCO Β· DGFT Verified
COOPER PHARMA is the #2 importer of Imatinib from India with $800.0K in import value and 16 verified shipments. COOPER PHARMA holds a 2.7% market share in Imatinib imports based in MOROCCO. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.

Verified from 16 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $800.0K | 16 | 100.0% |
COOPER PHARMA sources Imatinib from 1 verified Indian supplier based on 16 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.5M | 30 | $50.0K |
| 7 | JS BANK LTD. | PAKISTAN | $850.0K | 17 | $50.0K |
| 2 | COOPER PHARMA β | MOROCCO | $800.0K | 16 | $50.0K |
| 6 | HABIB BANK LIMITED | PAKISTAN | $750.0K | 15 | $50.0K |
| 4 | AUROBINDO PHARMA USA INC | UNITED STATES | $700.0K | 14 | $50.0K |
COOPER PHARMA ranks #2 among 456 Imatinib importers from India. Average shipment value of $50.0K compared to the market average of $19.3K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and JS BANK LTD..
Destination countries from 16 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $800.0K | 16 | 100.0% |
COOPER PHARMA imports Imatinib to 1 country. The primary destination is MOROCCO receiving 100.0% of shipments worth $800.0K.
| Formulation | Value | Shipments |
|---|---|---|
| IMATINIB COOPER 100 MG CAPSULES ( IMATIN | $200.0K | 4 |
| IMATINIB COOPER 100 MG CAPSULES IMATIN | $150.0K | 3 |
| IMATINIB COOPER 100 MG CAPSULES (IMATINIB MESYLATE (ALPHA FORM) 100MG) [1133(PACKS)X10X10'S] | $150.0K | 3 |
| IMATINIB COOPER 100 MG CAPSULES (IMATINI | $100.0K | 2 |
| IMATINIB COOPER 100 MG CAPSULES ( IMATINIB MESYLATE (ALPHA FORM) 100 MG) (INV.QTY.1170 PACK 10X10S=117000 NOS) | $100.0K | 2 |
| IMATINIB COOPER 100 MG CAPSULES ( IMATINIB MESYLATE (ALPHA FORM) 100 MG) (INV.QTY.1159 PACK 10X10S=115900 NOS) | $50.0K | 1 |
| IMATINIB COOPER 100 MG CAPSULES (IMATINIB MESYLATE (ALPHA FORM) 100MG) [1120(PACKS)X10X10'S] | $50.0K | 1 |
COOPER PHARMA imports 7 distinct Imatinib formulations from India.
Visual overview of India's imatinib buyer profile for COOPER PHARMA β top suppliers, destinations, pricing, and trade routes
India exported $8.8M worth of Imatinib through 1,726 shipments from 224 suppliers to 119 countries, serving 456 buyers globally. COOPER PHARMA imports $800.0K of this total, accounting for 2.7% of India's Imatinib exports with 16 shipments from MOROCCO. This is verified from 16 customs shipment records covering 7 distinct formulations.
COOPER PHARMA's average Imatinib order value is $50.0K per consignment, based on 16 shipments totaling $800.0K. COOPER PHARMA is based in MOROCCO and ranks #2 among all Imatinib importers from India by value. The company sources from 1 verified supplier in India.
COOPER PHARMA sources Imatinib from 1 verified Indian supplier: CIPLA LIMITED ($800.0K, 100.0%). This is based on 16 customs records.
COOPER PHARMA ranks #2 among 456 Imatinib importers from India with a 2.7% market share. The top 3 importers are AUROLOGISTICS LLC, (AUROBINDO PHARM ($1.5M), JS BANK LTD. ($850.0K), COOPER PHARMA ($800.0K). COOPER PHARMA processed 16 shipments from MOROCCO.
Latest developments and market context
Detailed market intelligence for Imatinib β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for COOPER PHARMA's Imatinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
COOPER PHARMA
Company Profile
Multiple products Β· $0 total trade Β· Multiple categories
Verified from customs records
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for COOPER PHARMA.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imatinib. For current order-level data, contact TransData Nexus.